C Benet-Campos1, C Cuéllar2, C García-Ballesteros1, V Zamora2, R Gil-Borrás3, I Catalán-Serra3,4,5, F López-Chuliá1, J C Andreu-Ballester6. 1. Hematology Department, Arnau de Vilanova Hospital, Valencia, Spain. 2. Department of Parasitology, Faculty of Pharmacy, Complutense University, Madrid, Spain. 3. Digestive Department, IBD Unit, Arnau de Vilanova Hospital, Valencia, Spain. 4. Internal Medicine, Gastroenterology Department, Levanger Hospital, Helse Nord-Trondelag, Levanger, Norway. 5. Centre of Molecular Inflammation Research (CEMIR), Norwegian Science and Technology University (NTNU), Trondheim, Norway. 6. Research Department, Arnau de Vilanova Hospital, c/San Clemente 12, 46015, Valencia, Spain. jcandreu@ono.com.
Abstract
BACKGROUND: The etiology of Crohn's disease (CD) is still unknown although new theories are based on defects in innate immunity. We have previously shown a decrease in γδ T cells in CD patients. Previous studies have shown a high prevalence of anti-A. simplex immunoglobulins in CD patients. The diminution of γδ T cells in the peripheral blood and intestinal mucosa of CD patients may create a state of immunosuppression that would facilitate A. simplex infection. AIMS: To study the antibody responses to Anisakis antigens in Crohn's disease patients and its relationship with αβ and γδ T cell subsets. METHODS: We recruited 81 CD patients and 81 healthy controls. αβ and γδ T cell subsets and anti-A. simplex antibodies were measured. RESULTS: Levels of anti-A. simplex IgG and IgM were significantly increased in CD patients. Almost 20% of CD patients were positive for IgG and IgM anti-A. simplex versus only 3.7 and 2.5%, respectively, in normal subjects. However, lower specific IgA levels were observed in the group of CD patients versus healthy subjects. We found an association between CD3 + CD8 + γδ subset and IgM anti-A. simplex levels. In ileal cases and stricturing behavior of CD, we observed the highest levels of specific antibodies with the exception of anti-A. simplex IgA. CONCLUSIONS: The relationship of specific antibodies with a γδ T cell deficiency makes these cell candidates to play a role in the immune response against Anisakis. In addition, anti-Anisakis antibodies could be considered as markers of risk of progression in CD.
BACKGROUND: The etiology of Crohn's disease (CD) is still unknown although new theories are based on defects in innate immunity. We have previously shown a decrease in γδ T cells in CDpatients. Previous studies have shown a high prevalence of anti-A. simplex immunoglobulins in CDpatients. The diminution of γδ T cells in the peripheral blood and intestinal mucosa of CDpatients may create a state of immunosuppression that would facilitate A. simplexinfection. AIMS: To study the antibody responses to Anisakis antigens in Crohn's diseasepatients and its relationship with αβ and γδ T cell subsets. METHODS: We recruited 81 CDpatients and 81 healthy controls. αβ and γδ T cell subsets and anti-A. simplex antibodies were measured. RESULTS: Levels of anti-A. simplex IgG and IgM were significantly increased in CDpatients. Almost 20% of CDpatients were positive for IgG and IgM anti-A. simplex versus only 3.7 and 2.5%, respectively, in normal subjects. However, lower specific IgA levels were observed in the group of CDpatients versus healthy subjects. We found an association between CD3 + CD8 + γδ subset and IgM anti-A. simplex levels. In ileal cases and stricturing behavior of CD, we observed the highest levels of specific antibodies with the exception of anti-A. simplex IgA. CONCLUSIONS: The relationship of specific antibodies with a γδ T cell deficiency makes these cell candidates to play a role in the immune response against Anisakis. In addition, anti-Anisakis antibodies could be considered as markers of risk of progression in CD.
Entities:
Keywords:
Anisakis simplex antibodies; Crohn’s disease; Immune deficiency; αβ T cells; γδ T cells
Authors: J C Andreu-Ballester; C García-Ballesteros; C Benet-Campos; V Amigó; A Almela-Quilis; J Mayans; F Ballester Journal: Cytometry B Clin Cytom Date: 2012-04-26 Impact factor: 3.058
Authors: M Montalto; L Miele; A Marcheggiano; L Santoro; V Curigliano; M Vastola; G Gasbarrini Journal: Dig Liver Dis Date: 2005-01 Impact factor: 4.088
Authors: R Paganelli; F Pallone; S Montano; S Le Moli; P M Matricardi; S Fais; P Paoluzi; R D'Amelio; F Aiuti Journal: Int Arch Allergy Appl Immunol Date: 1985
Authors: Frank H Klebl; Frauke Bataille; Claudia R Bertea; Hans Herfarth; Ferdinand Hofstädter; Jürgen Schölmerich; Gerhard Rogler Journal: Inflamm Bowel Dis Date: 2003-09 Impact factor: 5.325
Authors: Juan C Andreu-Ballester; Carlos Garcia-Ballesteros; Victoria Amigo; Ferran Ballester; Rafael Gil-Borrás; Ignacio Catalán-Serra; Angela Magnet; Soledad Fenoy; Carmen del Aguila; Jose Ferrando-Marco; Carmen Cuéllar Journal: PLoS One Date: 2013-04-18 Impact factor: 3.240
Authors: Lisa Frehn; Anke Jansen; Eveline Bennek; Ana D Mandic; Ilknur Temizel; Stefanie Tischendorf; Julien Verdier; Frank Tacke; Konrad Streetz; Christian Trautwein; Gernot Sellge Journal: PLoS One Date: 2014-09-12 Impact factor: 3.240